VR maker Jolly Good and Otsuka Pharmaceutical have signed an exclusive product development and sales deal to expand the use of social skill training VR in treating mental disorders in Japan.
The deal worth 5 billion yen ($43.7 million) will see Jolly Good delivering VR goggles and tablet devices and SST VR content. Otsuka will be compensating its partner for sales made at healthcare facilities,...
Japanese medical device maker Jolly Good and the Pain Center at the Aichi Medical University Hospital will conduct a study on the efficacy of virtual reality-based therapy for chronic pain.
It was in April last year that Jolly Good set up its digital therapeutics division, which involves a team of psychiatrists, pharmaceutical strategy specialists, and other DTx specialists. Through this, the...
Omron Healthcare, maker of health monitoring and therapy devices in Japan, has entered into a strategic partnership with Singapore-based telehealth startup Doctor Anywhere.
WHAT IT'S ABOUT
Under the partnership, Omron will enable the sharing of health records tracked on its connected devices with the DA platform. The integration involves the following Omron health monitoring devices: OMRON Smart...
Indian wellness startup K&L Wellness Technology scores $4M in seed funding
K&L Wellness Technology, a health technology startup in India, has bagged Rs 30 crore ($4 million) from angel investors to launch its wellness app.
According to a news report, the company seeks to redefine wellness through science-based personalised solutions.
K&L Wellness, also known as RESET Tech, provides...
Taiwan-based diabetes management app Health2Sync has launched the latest version of its mobile app for about 200,000 users in Japan that now integrates continuous glucose monitoring data from the Abbott FreeStyle LibreLink mobile app.
WHY IT MATTERS
This data integration, said Health2Sync in a statement, will enable comprehensive health management for people with diabetes. It will allow them to...
Sumitomo Dainippon Pharma Co. in Japan and US-based behavioural health firm BehaVR have signed definitive agreements to develop and market general wellness products and prescription digital therapeutics for the treatment of major mental health disorders.
WHAT IT'S ABOUT
Sumitomo Dainippon Pharma is engaged in the research and development of new pharmaceutical products in the areas of psychiatry...
ICT tech provider Fujitsu and the University of Tokyo Hospital in Japan have teamed up to develop an artificial intelligence tool for the early detection of heart diseases.
The partners announced on Monday that starting 25 October, they will enter a clinical research phase to verify the effectiveness of the technology in estimating abnormal heart movements based on electrocardiogram data.
WHAT IT...
Tokyo-based health and wellness startup Bisu has raised $3.2 million in a seed funding round led by South Korean biotechnology investor QUAD. The investing event was also joined by ASICS Ventures Corporation, 15th Rock Ventures, Pacifico Investments and SOSV.
WHAT IT'S FOR
Its seed funding will be used to formally bring into market its portable "home health lab" called Bisu Body Coach. The...
Israeli startup CytoReason has made its entry into Japan – the world's third-largest pharmaceutical market, upon signing a collaboration with Summit Pharmaceuticals International, the drug research and development arm of Sumitomo Corporation, one of the world's biggest general trading firms.
WHAT THEY DO
CytoReason develops computational disease models for drug discovery and development using...
A landmark clinical trial has found that a new digital therapeutic app for hypertension is effective in reducing the risks of cardiovascular and cerebrovascular diseases.
Japanese medical technology startup CureApp collaborated with Jichi Medical University in the Tochigi Prefecture to conduct the third phase of the said clinical trial, which marks the world's first trial of a therapeutic app for...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
